In Plain English: The Keynote 716 Clinical Trial
As of this writing, there are 477 clinical trials in melanoma on ClinicalTrial.gov that are actively recruiting patients—and another 65…
Blog - Melanoma360
09/05/2018
In Plain English: The Keynote 716 Clinical Trial
As of this writing, there are 477 clinical trials in melanoma on ClinicalTrial.gov that are actively recruiting patients—and another 65…
|
09/04/2018
Q&A With Three Leading Melanoma Specialists
Eric D. Whitman, MD Medical Director, Atlantic Health System Cancer Care Director, Atlantic Melanoma Center Question: Which clinical trials do…
|
08/30/2018
Melanoma By The State: Vermont
Vermont is a state known for national and state forests, majestic snow-covered mountains, delicious maple syrup, and Ben and Jerry’s…
|
04/26/2018
Jonathan Swingle, The Mucosal Melanoma Warrior
2009 was not a good year for Jonathan Swingle. Multiple nosebleeds led Jonathan to seek his doctor’s help, which…
|
07/31/2018
AIM Announces New Partnership With The Society for Immunotherapy of Cancer (SITC)
AIM at Melanoma is proud to announce our new online educational partnership with the Society for Immunotherapy of Cancer…
|
06/27/2018
For Tracy Welge, The Cure is in The Bag
Meet Tracy Welge, a 41-year-old wife, mother, and melanoma survivor from Naperville, Illinois. Two melanoma diagnoses, an entrepreneurial spirit, and a…
|
|
04/27/2018
Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute
Dr. Omid Hamid is recognized nationally and internationally as a key opinion leader in Immuno-Oncologic Drug Development and Melanoma…
|
04/27/2018
Sketching Her Way Through Metastatic Melanoma
By Alicia Rowell, Vice President, AIM at Melanoma Nearly every melanoma patient or survivor that AIM has met has a coping…
|
04/26/2018
Even America’s Heroes Get Melanoma
Meet Army Reserve veteran Erin Ball, who served eight years, including a tour in Iraq in 2004. She was…
|
03/07/2018
In Plain English… The Excitement Surrounding Opdivo
So the FDA granted regular approval to nivolumab (OPDIVO, Bristol-Myers Squibb Company) for the adjuvant treatment of patients with melanoma…
|
Recent Posts
Oct. 17, 2024
In Plain English: Update on Melanoma Vaccines, 2024
Oct. 15, 2024
Options For Stage II Melanoma: Making the Decision that’s Right For You
Oct. 10, 2024
Coolibar’s Generous Donation to the AIM at Melanoma Foundation
Oct. 10, 2024
Fall 2024 Newsletter
Oct. 10, 2024